Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas. A home-based palliative care program was ...

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality.